Sphingolipids in psychiatric disorders and pain syndromes

Handbook of Experimental Pharmacology

Volumn 216, Issue , 2013, Pages 431-456

  Muhle C ^a   Reichel, M ^a   Gulbins, E ^b   Kornhuber, J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Ceramide; Pain syndromes; Psychiatric disorders; Sphingolipids; Sphingomyelinase

Indexed keywords

CERAMIDE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

ALCOHOLISM; ANXIETY DISORDER; APOPTOSIS; ARTICLE; ENZYME LOCALIZATION; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; NERVE EXCITABILITY; NEUROPATHOLOGY; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; METABOLISM; REVIEW; SYNDROME;

ANIMALS; BRAIN; CERAMIDES; HUMANS; MENTAL DISORDERS; PAIN; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; SYNDROME;

MLCS; MLOWN;

EID: 84880553138     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-7091-1511-4_22     Document Type: Article

References (144)

1. Alt A, Nisenbaum ES, Bleakman D, Witkin JM (2006) A role for AMPA receptors in mood disorders. Biochem Pharmacol 71:1273-88
2. Alexander GM, van Rijn MA, van Hilten JJ, Perreault MJ, Schwartzman RJ (2005) Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain 116:213-219
3. Baraona E, Lieber CS (1979) Effects of ethanol on lipid metabolism. J Lipid Res 20:289-315
4. Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V, Wetsel WC, Lefkowitz RJ, Gainetdinov RR, Caron MG (2008) A ?-Arrestin 2 signaling complex mediates lithium action on behavior. Cell 132:125-136
5. Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55-68
6. Bianco F, Perrotta C, Novellino L, Francolini M, Riganti L, Menna E, Saglietti L, Schuchman EH, Furlan R, Clementi E, Matteoli M, Verderio C (2009) Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J 28:1043-1054
7. Bitanihirwe BKY, Woo TUW (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35:878-893
8. Bryant L, Doyle T, Chen Z, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Mazzon E, Petrusca DN, Petrache I, Salvemini D (2009) Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance. Neurosci Lett 463:49-53
9. Chang GHF, Barbaro NM, Pieper RO (2000) Phosphatidylserine-dependent phagocytosis of apoptotic glioma cells by normal human microglia, astrocytes, and glioma cells. Neuro Oncol 2:174-183
10. Cherayil GD (1969) Estimation of glycolipids in four selected lobes of human brain in neurological diseases. J Neurochem 16:913-920
11. Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis. 30:943-951
12. Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332-339
13. Contreras FX, Ernst AM, Haberkant P, Björkholm P, Lindahl E, Gönen B, Tischer C, Elofsson A, von Heijne G, Thiele C, Pepperkok R, Wieland F, Brügger B (2012) Molecular recognition of a single sphingolipid species by a protein's transmembrane domain. Nature 481:525-529
14. Corcoran CA, He Q, Ponnusamy S, Ogretmen B, Huang Y, Sheikh MS (2008) Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies. Mol Cancer Res 6:795-807
15. Coste O, Brenneis C, Linke B, Pierre S, Maeurer C, Becker W, Schmidt H, Gao W, Geisslinger G, Scholich K (2008a) Sphingosine 1-phosphate modulates spinal nociceptive processing. J Biol Chem 283:32442-32451
16. Coste O, Pierre S, Marian C, Brenneis C, Angioni C, Schmidt H, Popp L, Geisslinger G, Scholich K (2008b) Antinociceptive activity of the S1P-receptor agonist FTY720. J Cell Mol Med 12:995-1004
17. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J (2006) Cytokines and alcohol. Alcohol Clin Exp Res 30:720-730
18. Dadabhoy D, Crofford LJ, Spaeth M, Russell IJ, Clauw DJ (2008) Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 10:211
19. Davis CN, Tabarean I, Gaidarova S, Behrens MM, Bartfai T (2006) IL-1? induces a MyD88- dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J Neurochem 98:1379-1389
20. Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA (2001) Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 27:309-312
21. de Miranda AS, Lacerda-Queiroz N, de Carvalho VM, Rodrigues DH, Rachid MA, Quevedo J, Teixeira AL (2011) Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA). Neurosci Lett 491:202-206
22. Deaciuc IV, Nikolova-Karakashian M, Fortunato F, Lee EY, Hill DB, McClain CJ (2000) Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcohol Clin Exp Res 24:1557-1565
23. Demirkan A, van Duijn CM, Ugocsai P, Isaacs A, Pramstaller PP, Liebisch G, Wilson JF, Johansson A, Rudan I, Aulchenko YS, Kirichenko AV, Janssens ACJW, Jansen RC, Gnewuch C, Domingues FS, Pattaro C, Wild SH, Jonasson I, Polasek O, Zorkoltseva IV, Hofman A, Karssen LC, Struchalin M, Floyd J, Igl W, Biloglav Z, Broer L, Pfeufer A, Pichler I, Campbell S, Zaboli G, Kolcic I, Rivadeneira F, Huffman J, Hastie ND, Uitterlinden A, Franke L, Franklin CS, Vitart V, Nelson CP, Preuss M, Bis JC, O'Donnell CJ, Franceschini N, Witteman JCM, Axenovich T, Oostra BA, Meitinger T, Hicks AA, Hayward C, Wright AF, Gyllensten U, Campbell H, Schmitz G (2012) Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations. PLoS Genet 8:e1002490
24. Demirkan A, Isaacs A, Ugocsai P, Liebisch G, Struchalin M, Rudan I, Wilson JF, Pramstaller PP, Gyllensten U, Campbell H, Schmitz G, Oostra BA, Van Duijn CM (2012) Plasma phosphatidylcholine and sphingomyelin concentrations are associated with depression and anxiety symptoms in a Dutch family-based lipidomics study. J Psychiatr Res pii:S0022-3956(12) 00341
25. X Demisch L, Heinz K, Gerbaldo H, Kirsten R (1992) Increased concentrations of phosphatidylinositol (PI) and decreased esterification of arachidonic acid into phospholipids in platelets from patients with schizoaffective disorders or atypic phasic psychoses. Prostaglandins Leukot Essent Fatty Acids 46:47-52
26. DeVito WJ, Stone S, Shamgochian M (2000) Ethanol increases the neurotoxic effect of tumor necrosis factor-Alpha in cultured rat astrocytes. Alcohol Clin Exp Res 24:82-92
27. Doyle T, Chen Z, Obeid LM, Salvemini D (2011) Sphingosine-1-phosphate acting via the S1P receptor is a downstream signaling pathway in ceramide-induced hyperalgesia. Neurosci Lett 499:4-8
28. Duan RD, Hertervig E, Nyberg L, Hauge T, Sternby B, Lillienau J, Farooqi A, Nilsson A (1996) Distribution of alkaline sphingomyelinase activity in human beings and animals. Tissue and species differences. Dig Dis Sci 41:1801-1806
29. Edsall LC, Van Brocklyn JR, Cuvillier O, Kleuser B, Spiegel S (1998) N, N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 37:12892-12898
30. El Bawab S, Bielawska A, Hannun YA (1999) Purification and characterization of a membranebound nonlysosomal ceramidase from rat brain. J Biol Chem 274:27948-27955
31. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004) Convergent evidence for impaired AKT1-GSK3? signaling in schizophrenia. Nat Genet 36:131-137
32. Fernández A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC (2008) Cholesterol and sphingolipids in alcohol-induced liver injury. J Gastroenterol Hepatol 23(Suppl 1):S9-S15
33. Fukuzako H, Fukuzako T, Hashiguchi T, Kodama S, Takigawa M, Fujimoto T (1999) Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am J Psychiatry 156:1205-1208
34. Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, Park JY, Lind AL, Ma Q, Ji RR (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29:4096-4108
35. Garofalo K, Penno A, Schmidt BP, Lee HJ, Frosch MP, von Eckardstein A, Brown RH, Hornemann T, Eichler FS (2011) Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. J Clin Invest 121:4735-4745
36. Gatt S (1963) Enzymic hydrolysis and synthesis of ceramides. J Biol Chem 238:3131-3133
37. Gilmore N, Cherian L, Klemm WR (1991) Ganglioside or sialic acid attenuates ethanol-induced decrements in locomotion, nose-poke exploration, and anxiety, but not body temperature. Prog Neuropsychopharmacol Biol Psychiatry 15:91-104
38. Glasier MM, Sutton RL, Stein DG (1995) Effects of unilateral entorhinal cortex lesion and ganglioside GM1 treatment on performance in a novel water maze task. Neurobiol Learn Mem 64:203-214
39. Gracia-Garcia P, Rao V, Haughey NJ, Banduru VVR, Smith G, Rosenberg PB, Lobo A, Lyketsos CG, Mielke MM (2011) Elevated plasma ceramides in depression. J Neuropsychiatry Clin Neurosci 23:215-218
40. Grassmé H, Jendrossek V, Riehle A, von KG, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E (2003) Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9:322-330
41. Grassmé H, Riehle A, Wilker B, Gulbins E (2005) Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 280:26256-26262
42. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK III, Schuchman EH, Fuks Z, Kolesnick R (1997) Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186:1831-1841
43. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S (2006) Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochem Biophys Acta 1758:2016-2026
44. Haselhorst U, Schenk H, Beyer I, Uebelhack R, Franke E, Kielstein V (1988) Abnormality of gangliosides in erythrocyte membranes of schizophrenic patients. Clin Physiol Biochem 6:281-284
45. Hicks AA, Pramstaller PP, Johansson A, Vitart V, Rudan I, Ugocsai P, Aulchenko Y, Franklin CS, Liebisch G, Erdmann J, Jonasson I, Zorkoltseva IV, Pattaro C, Hayward C, Isaacs A, Hengstenberg C, Campbell S, Gnewuch C, Janssens ACJW, Kirichenko AV, König IR, Marroni F, Polasek O, Demirkan A, Kolcic I, Schwienbacher C, Igl W, Biloglav Z, Witteman JCM, Pichler I, Zaboli G, Axenovich TI, Peters A, Schreiber S, Wichmann HE, Schunkert H, Hastie N, Oostra BA, Wild SH, Meitinger T, Gyllensten U, van Duijn CM, Wilson JF, Wright A, Schmitz G, Campbell H (2009) Genetic determinants of circulating sphingolipid concentrations in European populations. PLoS Genet 5:e1000672
46. Hitzemann R, Hirschowitz J, Panini A, Mark C, Garver D (1984) Membranes, methylation and lithium responsive psychoses. Nutr Health 3:153-162
47. Hitzemann R, Mark C, Hirschowitz J, Garver D (1985) Characteristics of phospholipid methylation in human erythrocyte ghosts: relationship(s) to the psychoses and affective disorders. Biol Psychiatry 20:397-407
48. Hofmann K, Tomiuk S, Wolff G, StoffelW(2000) Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc Natl Acad Sci USA 97:5895-5900
49. Hofmeister R, Wiegmann K, Korherr C, Bernardo K, Krönke M, FalkW(1997) Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein. J Biol Chem 272:27730-27736
50. Holopainen JM, Angelova MI, Kinnunen PK (2000) Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys J 78:830-838
51. Horrobin DF (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30:193-208
52. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-Analysis. Psychosom Med 71:171-186
53. Jafurulla M, Pucadyil TJ, Chattopadhyay A (2008) Effect of sphingomyelinase treatment on ligand binding activity of human serotonin1A receptors. Biochim Biophys Acta 1778:2022-2025
54. Jang S, Suh SH, Yoo HS, Lee YM, Oh S (2008) Changes in iNOS, GFAP and NR1 expression in various brain regions and elevation of sphingosine-1-phosphate in serum after immobilized stress. Neurochem Res 33:842-851
55. Jang S, Kim D, Lee Y, Moon S, Oh S (2011) Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. Neurochem Res 36:258-267
56. Jung SY, Suh JH, Park HJ, Jung KM, Kim MY, Na DS, Kim DK (2000) Identification of multiple forms of membrane-Associated neutral sphingomyelinase in bovine brain. J Neurochem 75:1004-1014
57. Keshavan MS, Mallinger AG, Pettegrew JW, Dippold C (1993) Erythrocyte membrane phospholipids in psychotic patients. Psychiatry Res 49:89-95
58. Kim SK, Ahn KH, Ji JE, Choi JM, Jeon HJ, Jung SY, Jung KM, Kim DK (2010) Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium. Cell Signal 22:865-870
59. Klein R, Berg PA (1995) High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res 1:21-26
60. Klein R, Bänsch M, Berg PA (1992) Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17:593-598
61. Kornhuber J, Medlin A, Bleich S, Jendrossek V, Henkel AW, Wiltfang J, Gulbins E (2005) High activity of acid sphingomyelinase in major depression. J Neural Transm 112:1583-1590
62. Kornhuber J, Tripal P, ReichelM, Terfloth L, Bleich S, Wiltfang J, Gulbins E (2008) Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-Activity relation model. J Med Chem 51:219-237
63. Kornhuber J, Reichel M, Tripal P, Groemer TW, Henkel AW, Mühle C, Gulbins E (2009) The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2): S199-S204
64. Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer TW, Spitzer GM, Liedl KR, Gulbins E, Tripal P (2011) Identification of novel functional inhibitors of acid sphingomyelinase. PLoS One 6:e23852
65. Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, KrönkeM(2006) Novel tumor necrosis factorresponsive mammalian neutral sphingomyelinase-3 is a C-tail-Anchored protein. J Biol Chem 281:13784-13793
66. Kubicki M, McCarley RW, Shenton ME (2005) Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry 18:121-134
67. Latorre E, Aragonés MD, Fernández I, Catalán RE (1999) Platelet-Activating factor modulates brain sphingomyelin metabolism. Eur J Biochem 262:308-314
68. Lee YK, Kim HL, Kim YL, Im DS (2007) Multiple actions of dimethylsphingosine in 1321N1 astrocytes. Mol Cells 23:11-16
69. Lesch P, Schmidt E, Schmidt FW (1973) Effects of chronic alcohol abuse on the fatty acid composition of major lipids in the human brain. Hepatocerebral degeneration II. Z Klin Chem Klin Biochem 11:159-166
70. Levade T, Salvayre R, Potier M, Douste-Blazy L (1986) Interindividual heterogeneity of molecular weight of human brain neutral sphingomyelinase determined by radiation inactivation method. Neurochem Res 11:1131-1138
71. Liangpunsakul S, Sozio MS, Shin E, Zhao Z, Xu Y, Ross RA, Zeng Y, Crabb DW (2010) Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels. Am J Physiol Gastrointest Liver Physiol 298:G1004-G1012
72. Liangpunsakul S, Rahmini Y, Ross RA, Zhao Z, Xu Y, Crabb DW (2012) Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol 302:G515-G523
73. Liu JJ, Wang JY, Hertervig E, Cheng Y, Nilsson A, Duan RD (2000) Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol 35:569-573
74. MacQueen GM, Rosebush PI, Mazurek MF (1998) Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci 10:10-19
75. Mann JJ (1999) Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology 21:99S-105S
76. Mar?́ M, Colell A, Morales A, Pañeda C, Varela-Nieto I, Garcia-Ru?́z C, Fernández-Checa JC (2004) Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest 113:895-904
77. Mora A, Sabio G, Risco AM, Cuenda A, Alonso JC, Soler G, Centeno F (2002) Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal 14:557-562
78. Müller N, Ackenheil M (1998) Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 22:1-33
79. Muscoli C, Doyle T, Dagostino C, Bryant L, Chen Z, Watkins LR, Ryerse J, Bieberich E, Neumman W, Salvemini D (2010) Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. J Neurosci 30:15400-15408
80. Musselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55:580-592
81. Nalivaeva NN, Rybakina EG, Pivanovich IY, Kozinets IA, Shanin SN, Bartfai T (2000) Activation of neutral sphingomyelinase by IL-1beta requires the type 1 interleukin 1 receptor. Cytokine 12:229-232
82. Narayan S, Kass KE, Thomas EA (2007) Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain. J Neurosci Res 85:757-765
83. Narayan S, Head SR, Gilmartin TJ, Dean B, Thomas EA (2009) Evidence for disruption of sphingolipid metabolism in schizophrenia. J Neurosci Res 87:278-288
84. Ndengele MM, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Muscoli C, Petrusca DN, Mollace V, Mazzon E, Li D, Petrache I, Matuschak GM, Salvemini D (2009) Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation. J Pharmacol Exp Ther 329:64-75
85. Ng F, Berk M, Dean O, Bush AI (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851-876
86. Nie H, Weng HR (2010) Impaired glial glutamate uptake induces extrasynaptic glutamate spillover in the spinal sensory synapses of neuropathic rats. J Neurophysiol 103:2570-2580
87. Norman E, Cutler RG, Flannery R, Wang Y, Mattson MP (2010) Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms. J Neurochem 114:430-439
88. Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604-616
89. Okino N, He X, Gatt S, Sandhoff K, Ito M, Schuchman EH (2003) The reverse activity of human acid ceramidase. J Biol Chem 278:29948-29953
90. Olsson NU, Harding AJ, Harper C, Salem N Jr (1996) High-performance liquid chromatography method with light-scattering detection for measurements of lipid class composition: analysis of brains from alcoholics. J Chromatogr B Biomed Appl 681:213-218
91. Ono M, Kikusui T, Sasaki N, Ichikawa M, Mori Y, Murakami-Murofushi K (2008) Early weaning induces anxiety and precocious myelination in the anterior part of the basolateral amygdala of male Balb/c mice. Neuroscience 156:1103-1110
92. Pascual M, Valles SL, Renau-Piqueras J, Guerri C (2003) Ceramide pathways modulate ethanolinduced cell death in astrocytes. J Neurochem 87:1535-1545
93. Patti GJ, Yanes O, Shriver LP, Courade JP, Tautenhahn R, Manchester M, Siuzdak G (2012) Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol 8:232-234
94. Perrotta C, Bizzozero L, Cazzato D, Morlacchi S, Assi E, Simbari F, Zhang Y, Gulbins E, Bassi MT, Rosa P, Clementi E (2010) Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function. J Biol Chem 285:40240-40251
95. Ponizovsky AM, Modai I, Nechamkin Y, Barshtein G, Ritsner MS, Yedgar S, Lecht S, Bergelson LD (2001) Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology. Schizophr Res 52:121-126
96. Posse de Chaves E, Sipione S (2010) Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction. FEBS Lett 584:1748-1759
97. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801-808
98. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A (2007) No health without mental health. Lancet 370:859-877
99. Qin J, Berdyshev E, Poirier C, Schwartz NB, Dawson G (2012) Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of hyaluronan synthase 2 through decreased ceramide production and activation of Akt. J Biol Chem 287(17):13620-13632
100. Rao BG, Spence MW (1976) Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res 17:506-515
101. Reichel M, Greiner E, Richter-Schmidinger T, Yedibela O ̈ , Tripal P, Jacobi A, Bleich S, Gulbins E, Kornhuber J (2010) Increased acid sphingomyelinase activity in peripheral blood cells of acutely intoxicated patients with alcohol dependence. Alcohol Clin Exp Res 34:46-50
102. Reichel M, Beck J, Mühle C, Rotter A, Bleich S, Gulbins E, Kornhuber J (2011) Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients. Alcohol Clin Exp Res 35:1852-1859
103. Reitz RC (1979) The effects of ethanol ingestion on lipid metabolism. Prog Lipid Res 18:87-115
104. Riddle EL, Rau KS, Topham MK, Hanson GR, Fleckenstein AE (2003) Ceramide-induced alterations in dopamine transporter function. Eur J Pharmacol 458:31-36
105. Rogasevskaia T, Coorssen JR (2006) Sphingomyelin-enriched microdomains define the efficiency of native Ca2+-triggered membrane fusion. J Cell Sci 119:2688-2694
106. Rohrbough J, Rushton E, Palanker L, Woodruff E, Matthies HJ, Acharya U, Acharya JK, Broadie K (2004) Ceramidase regulates synaptic vesicle exocytosis and trafficking. J Neurosci 24:7789-7803
107. Saito M, Saito M, Cooper TB, Vadasz C (2005) Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. Alcohol Clin Exp Res 29:1374-1383
108. Sánchez C, Rueda D, Ségui B, Galve-Roperh I, Levade T, Guzmán M (2001) The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol Pharmacol 59:955-959
109. Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-935
110. Sawai H, Hannun YA (1999) Ceramide and sphingomyelinases in the regulation of stress responses. Chem Phys Lipids 102:141-147
111. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, Assi LK, Parkes N, Clough LE, Gulbins E, Salmon M, Lord JM (2004) Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 104:2557-2564
112. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I (1998) The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273:18250-18259
113. Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G, Braus DF, Gattaz WF (2004) Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry 56:41-45
114. Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S (2008) High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 7:4266-4277
115. Sjögren B, Svenningsson P (2007) Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells. Acta Physiol 190:47-53
116. Smesny S, Schmelzer CE, Hinder A, Kohler A, Schneider C, Rudzok M, Schmidt U, Milleit B, Milleit C, Nenadic I, Sauer H, Neubert RH, Fluhr JW (2012) Skin ceramide alterations In firstepisode schizophrenia indicate abnormal sphingolipid metabolism. Schizophr Bull doi:10.1093/schbul/sbs058
117. Spence MW, Burgess JK (1978) Acid and neutral sphingomyelinases of rat brain. Activity in developing brain and regional distribution in adult brain. J Neurochem 30:917-919
118. Spence MW, Burgess JK, Sperker ER (1979) Neutral and acid sphingomyelinases: somatotopographical distribution in human brain and distribution in rat organs. A possible relationship with the dopamine system. Brain Res 168:543-551
119. Spence MW, Beed S, Cook HW (1986) Acid and alkaline ceramidases of rat tissues. Biochem Cell Biol 64:400-404
120. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, Olivera A, Pirianov G, Thomas DM, Tu Z, Van Brocklyn JR, Wang F (1998) Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci 845:11-18
121. Sugita M, Willians M, Dulaney JT, Moser HW (1975) Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim Biophys Acta 398:125-131
122. Sulem P, Gudbjartsson DF, Geller F, Prokopenko I, Feenstra B, Aben KK, Franke B, den Heijer M, Kovacs P, Stumvoll M, Mägi R, Yanek LR, Becker LC, Boyd HA, Stacey SN, Walters GB, Jonasdottir A, Thorleifsson G, Holm H, Gudjonsson SA, Rafnar T, Björnsdottir G, Becker DM, Melbye M, Kong A, Tönjes A, Thorgeirsson T, Thorsteinsdottir U, Kiemeney LA, Stefansson K (2011) Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet 20:2071-2077
123. Tabatadze N, Savonenko A, Song H, Bandaru VVR, Chu M, Haughey NJ (2010) Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice. J Neurosci Res 88:2940-2951
124. Tandon K, McGuffin P (2002) The genetic basis for psychiatric illness in man. Eur J Neurosci 16:403-407
125. Terracciano A, Sanna S, Uda M, Deiana B, Usala G, Busonero F, Maschio A, Scally M, Patriciu N, Chen WM, Distel MA, Slagboom EP, Boomsma DI, Villafuerte S, Sliwerska E, Burmeister M, Amin N, Janssens AC, van Duijn CM, Schlessinger D, Abecasis GR, Costa PT Jr (2010) Genome-wide association scan for five major dimensions of personality. Mol Psychiatry 15:647-656
126. Thayyullathil F, Chathoth S, Hago A, Patel M, Szulc ZM, Hannun Y, Galadari S (2011) Purification and characterization of a second type of neutral ceramidase from rat brain: a second more hydrophobic form of rat brain ceramidase. Biochim Biophys Acta 1811:242-252
127. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W (1998) Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 95:3638-3643
128. Toro C, Deakin JF (2005) NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80:323-30
129. Wallis CJ, Rezazadeh SM, Lal H (1995) GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence. Alcohol 12:573-580
130. Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455
131. Weinreb NJ, Brady RO, Tappel AL (1968) The lysosomal localization of sphingolipid hydrolases. Biochim Biophys Acta 159:141-146
132. Werle E, Fischer HP, Müller A, Fiehn W, Eich W (2001) Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rheumatol 28:595-600
133. Wheeler D, Knapp E, Bandaru VVR, Wang Y, Knorr D, Poirier C, Mattson MP, Geiger JD, Haughey NJ (2009) Tumor necrosis factor-?-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem 109:1237-1249
134. Wolf G, Gabay E, Tal M, Yirmiya R, Shavit Y (2006) Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 120:315-324
135. Wolff RA, Dobrowsky RT, Bielawska A, Obeid LM, Hannun YA (1994) Role of ceramideactivated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 269:19605-19609
136. Wong ML, Xie B, Beatini N, Phu P, Marathe S, Johns A, Gold PW, Hirsch E, Williams KJ, Licinio J, Tabas I (2000) Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA 97:8681-8686
137. Wu D, Cederbaum AI (2009) Oxidative stress and alcoholic liver disease. Semin Liver Dis 29:141-154
138. Yang SN (2000) Ceramide-induced sustained depression of synaptic currents mediated by ionotropic glutamate receptors in the hippocampus: an essential role of postsynaptic protein phosphatases. Neuroscience 96:253-258
139. Yao JK, Leonard S, Reddy RD (2000) Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 42:7-17
140. Zha X, Pierini LM, Leopold PL, Skiba PJ, Tabas I, Maxfield FR (1998) Sphingomyelinase treatment induces ATP-independent endocytosis. J Cell Biol 140:39-47
141. Zhang Y, Li X, Carpinteiro A, Gulbins E (2008) Acid sphingomyelinase amplifies redox signaling in Pseudomonas aeruginosa-induced macrophage apoptosis. J Immunol 181:4247-4254
142. Zhang Y, Li X, Becker KA, Gulbins E (2009) Ceramide-enriched membrane domains-structure and function. Biochim Biophys Acta 1788:178-183
143. Zhang H, Li D, Su Y, Jiang S, Xu Y, Jiang K, Cui D (2012) Identification of the N-Acylsphingosine amidohydrolase 1 gene (ASAH1) for susceptibility to schizophrenia in a Han Chinese population. World J Biol Psychiatry 13:106-113
144. Zhao Z, Yu M, Crabb D, Xu Y, Liangpunsakul S (2011) Ethanol-induced alterations in fatty acidrelated lipids in serum and tissues in mice. Alcohol Clin Exp Res 35:229-234